H Schulze

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study

Andreas Stallmach, C. Langbein, Raja Atreya et al. · Alimentary Pharmacology & Therapeutics · 2016 · 163 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Rat Brain Glyceraldehyde‐3‐Phosphate Dehydrogenase Interacts with the Recombinant Cytoplasmic Domain of Alzheimer's β‐Amyloid Precursor Protein

H Schulze, Angelika Schuler, Dietrich Stüber et al. · Journal of Neurochemistry · 1993 · 124 citations

Life Sciences, Biochemistry, Neuroscience +17

Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s Disease

Torsten Kucharzik, Rune Wilkens, Maria Antonietta D’Agostino et al. · Clinical Gastroenterology and Hepatology · 2022 · 97 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn’s disease

Wolfgang Alexander Seeger, Juliane Thieringer, Philip Esters et al. · United European Gastroenterology Journal · 2020 · 46 citations · Full text

Medicine, Rehabilitation Medicine, Exercise Physiology +16

A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients

H Schulze, Philip Esters, Franz Hartmann et al. · Scandinavian Journal of Gastroenterology · 2018 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +16